Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Small-Cap with Disruptive Real Estate Agent Platform Provides 'Blue-Sky' Potential

As the groundbreaking real-estate industry platform provides "disruption from the inside," the company moves to monetize its asset. Publicly traded small-cap RESAAS Services Inc. (RSS:TSX.V; RSASF:OTCQB) is changing the way real estate professionals do business. Its a...
Streetwise Reports | March 1, 2019 |

Ely Gold's New Option/Royalty Model Provides Opportunities

This company is transforming the model for mineral exploration in the Western United States. Ely Gold Royalties Inc. (ELY:TSX.V; ELYGF:OTCQB) has turned the parameters and expectations of a typical project generator around by substituting the traditional joint venture b...
Streetwise Reports | March 1, 2019 |

Valeo Pharma Big Pharma Capabilities Presents Opportunity

Valeo Pharma Inc. is a Canadian specialty pharmaceutical company with big pharma capabilities while retaining small company flexibilities. Valeo is a fast-growing revenue generating company with a strong product portfolio and a robust product pipeline. Valeo Pharma In...
Fredrick William | May 15, 2020 |

DEATH OF AN ILL-FATED BULL MARKET AND BIRTH OF A CLEAN ENERGY INFRASTRUCTURE OF RESILIENCE

ZAIR: SHIFT THE PERSPECTIVE With stock markets crashing like there was no tomorrow, the fear of a global recession is becoming a reality. During such times, smart institutional and private investors don‘t watch from the sidelines but are deploying their capital...
Stephan Bogner | March 18, 2020 |

A Deep Dig into the Largest VMS District in the World

For metals & mining investors, copper has long been one of the planet’s most in-demand metals. But the shine on this versatile industrial metal has dulled over the past number of years, as overall, investment hasn’t kept up with consumption a...
Dave Jackson | January 3, 2020 |

Fact: Cybersecurity is One of the World’s Fastest Growing Investment Opportunities

(Click image to play video) Cybersecurity attacks continue to be an existential threat to businesses and organizations – particularly as the move to continue to work from home in the wake of COVID-19 becomes more prevalent – and shows no signs of slowing down. I...
Dave Jackson | May 18, 2021 |

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

Shares of Navidea Biopharmaceuticals traded 60% higher today on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. Developer of precision immunodiagnostic agents and immunotherape...
Streetwise Reports | October 30, 2019 |

Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax

Shares of Paratek Pharmaceuticals traded 40% higher today after the firm announced it was awarded a BARDA BioShield program contract valued at up to $285 million for NUZYRA used to treat anthrax. Late yesterday afternoon, biopharmaceutical company Paratek Pharmaceuti...
Streetwise Reports | December 20, 2019 |

NantKwest Shares Jump More than 50% Following JP Morgan Healthcare Conference Presentation

Shares of NantKwest Inc. spiked as much as 85% higher in mid-morning trading setting a new 52-week high price after the company reported a series of positive results at the 38th J.P. Morgan Healthcare Conference in San Francisco. The firm reported that complete responses were ...
Streetwise Reports | January 17, 2020 |

Imagin Medical Poised for Breakout with Bladder Cancer Detection Device in FDA Approval Process

A new advancement in bladder-related endoscopic surgery is endorsed and de-risked. You don't often hear about it, but bladder cancer is the sixth most common cancer in the U.S., with approximately 80,000 cases reported every year, and some 600,000 Americans living in ...
Streetwise Reports | November 13, 2019 |
1 2 3 4 5 6 7 8 9 10 ...